% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Pinkawa:808538,
author = {Pinkawa, Michael and Brzozowska, Kinga and Kriehuber, Ralf
and Eble, Michael J and Schmitz, Sabine},
title = {{P}rediction of radiation-induced toxicity by in vitro
radiosensitivity of lymphocytes in prostate cancer patients},
journal = {Future oncology},
volume = {12},
number = {5},
issn = {1744-8301},
address = {London},
publisher = {Future Medicine Ltd},
reportid = {FZJ-2016-02276},
pages = {617 - 624},
year = {2016},
abstract = {Aim: To identify predictive assays for radiation-induced
toxicity in prostate cancer patients.Patients $\&$ methods:
Patients have been surveyed prospectively before and up to
16 monthsafter radiotherapy using a validated questionnaire.
Subgroups of 25 patients with minorand larger score changes,
respectively, were selected for γ-H2AX, G2 and Annexin V
assays.Results: A significantly higher spontaneous chromatid
aberration yield (HR: 1.46 $[95\%$ CI:1.02–2.09]; p =
0.04), higher levels of early apoptotic (HR: 1.12 $[95\%$
CI: 1.01–1.24]; p = 0.04) andlate apoptotic and necrotic
(HR: 1.10 $[95\%$ CI: 0.99–1.23]; p = 0.08) lymphocytes
24-h postirradiationwere found in patients with a bowel
bother score decrease greater than 20 pointsmore than 1 year
after treatment. Conclusion: Chromatid aberration and
apoptosis/necrosisassays appear to be suitable for the
prediction of radiation-induced toxicity.},
cin = {S-US},
ddc = {610},
cid = {I:(DE-Juel1)S-US-20090406},
pnm = {899 - ohne Topic (POF3-899)},
pid = {G:(DE-HGF)POF3-899},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000370695600008},
doi = {10.2217/fon.15.334},
url = {https://juser.fz-juelich.de/record/808538},
}